Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 6
2008 2
2009 5
2010 1
2011 2
2012 2
2013 10
2014 5
2015 6
2016 9
2017 9
2018 18
2019 13
2020 19
2021 24
2022 37
2023 26
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Dermatitis, atopic, 6"
Page 1
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.
Drucker AM, Morra DE, Prieto-Merino D, Ellis AG, Yiu ZZN, Rochwerg B, Di Giorgio S, Arents BWM, Burton T, Spuls PI, Schmitt J, Flohr C. Drucker AM, et al. JAMA Dermatol. 2022 May 1;158(5):523-532. doi: 10.1001/jamadermatol.2022.0455. JAMA Dermatol. 2022. PMID: 35293977 Free PMC article.
IMPORTANCE: Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates for treatments that have not been compared head to head. OBJECTIVE: To compare …
IMPORTANCE: Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta …
Prevalence and Incidence of Atopic Dermatitis: A Systematic Review.
Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Bylund S, et al. Acta Derm Venereol. 2020 Jun 9;100(12):adv00160. doi: 10.2340/00015555-3510. Acta Derm Venereol. 2020. PMID: 32412646 Free PMC article.
The primary objective of this study was to systematically review and analyse epidemiological studies of the prevalence and incidence of atopic dermatitis (AD) during childhood and adulthood, focusing on data from the 21st century. ...In the 21st century, the 1-year …
The primary objective of this study was to systematically review and analyse epidemiological studies of the prevalence and incidence of a …
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Chu AWL, Wong MM, Rayner DG, Guyatt GH, Díaz Martinez JP, Ceccacci R, Zhao IX, McMullen E, Srivastava A, Wang J, Wen A, Wang FC, Brignardello-Petersen R, Izcovich A, Oykhman P, Wheeler KE, Wang J, Spergel JM, Singh JA, Silverberg JI, Ong PY, O'Brien M, Martin SA, Lio PA, Lind ML, LeBovidge J, Kim E, Huynh J, Greenhawt M, Gardner DD, Frazier WT, Ellison K, Chen L, Capozza K, De Benedetto A, Boguniewicz M, Smith Begolka W, Asiniwasis RN, Schneider LC, Chu DK. Chu AWL, et al. J Allergy Clin Immunol. 2023 Dec;152(6):1470-1492. doi: 10.1016/j.jaci.2023.08.029. Epub 2023 Sep 9. J Allergy Clin Immunol. 2023. PMID: 37678577 Free article.
BACKGROUND: Atopic dermatitis (AD) is an inflammatory skin condition with multiple systemic treatments and uncertainty regarding their comparative impact on AD outcomes. ...With high-certainty evidence, high-dose upadacitinib was among the most effective for 5 of …
BACKGROUND: Atopic dermatitis (AD) is an inflammatory skin condition with multiple systemic treatments and uncertainty regardi …
Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.
Bosma AL, Ascott A, Iskandar R, Farquhar K, Matthewman J, Langendam MW, Mulick A, Abuabara K, Williams HC, Spuls PI, Langan SM, Middelkamp-Hup MA. Bosma AL, et al. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):807-819. doi: 10.1111/jdv.18008. Epub 2022 Feb 25. J Eur Acad Dermatol Venereol. 2022. PMID: 35170821 Free PMC article. Review.
We aimed to systematically review previously reported phenotypes of atopic dermatitis and any characteristics associated with them. Ovid EMBASE, Ovid MEDLINE and Web of Science were searched from inception till 12 February 2021 for studies attempting to classify …
We aimed to systematically review previously reported phenotypes of atopic dermatitis and any characteristics associated with …
Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis.
Silverberg JI, Thyssen JP, Fahrbach K, Mickle K, Cappelleri JC, Romero W, Cameron MC, Myers DE, Clibborn C, DiBonaventura M. Silverberg JI, et al. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):1797-1810. doi: 10.1111/jdv.17351. Epub 2021 Jun 12. J Eur Acad Dermatol Venereol. 2021. PMID: 33991374 Free PMC article. Review.
Given the lack of head-to-head studies of systemic therapies in moderate-to-severe atopic dermatitis (AD), network meta-analyses (NMAs) can provide comparative efficacy and safety data to inform clinical decision-making. ...In monotherapy RCTs, upadacitinib 30 mg on …
Given the lack of head-to-head studies of systemic therapies in moderate-to-severe atopic dermatitis (AD), network meta-analys …
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Chu DK, Chu AWL, Rayner DG, Guyatt GH, Yepes-Nuñez JJ, Gomez-Escobar L, Pérez-Herrera LC, Díaz Martinez JP, Brignardello-Petersen R, Sadeghirad B, Wong MM, Ceccacci R, Zhao IX, Basmaji J, MacDonald M, Chu X, Islam N, Gao Y, Izcovich A, Asiniwasis RN, Boguniewicz M, De Benedetto A, Capozza K, Chen L, Ellison K, Frazier WT, Greenhawt M, Huynh J, LeBovidge J, Lio PA, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel JM, Smith Begolka W, Wang J, Wheeler KE, Gardner DD, Schneider L. Chu DK, et al. J Allergy Clin Immunol. 2023 Dec;152(6):1493-1519. doi: 10.1016/j.jaci.2023.08.030. Epub 2023 Sep 9. J Allergy Clin Immunol. 2023. PMID: 37678572 Free article.
BACKGROUND: Atopic dermatitis (AD) is a common skin condition with multiple topical treatment options, but uncertain comparative effects. ...With moderate- to high-certainty evidence, group 5 TCS improved 6-among the best for 3; group 4 TCS and delgocitinib i …
BACKGROUND: Atopic dermatitis (AD) is a common skin condition with multiple topical treatment options, but uncertain comparati …
Treatment With Dupilumab in Patients With Atopic Dermatitis: Systematic Review and Meta-Analysis.
Koskeridis F, Evangelou E, Ntzani EE, Kostikas K, Tsabouri S. Koskeridis F, et al. J Cutan Med Surg. 2022 Nov-Dec;26(6):613-621. doi: 10.1177/12034754221130969. Epub 2022 Oct 9. J Cutan Med Surg. 2022. PMID: 36214355 Review.
Atopic dermatitis (AD) is a type 2 chronic skin disorder associated with systemic and psychosocial comorbidities decreasing the quality of life for many patients. ...Dupilumab decreased the Eczema Area Severity Index (EASI) score [standardized mean difference (SMD) …
Atopic dermatitis (AD) is a type 2 chronic skin disorder associated with systemic and psychosocial comorbidities decreasing th …
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study.
Tian J, Zhang D, Yang Y, Huang Y, Wang L, Yao X, Lu Q. Tian J, et al. Br J Dermatol. 2023 Dec 20;190(1):55-61. doi: 10.1093/bjd/ljad339. Br J Dermatol. 2023. PMID: 37705227
BACKGROUND: Atopic dermatitis (AD) is the leading cause of the global burden from skin disease; no study has provided global and country-specific epidemiological estimates of AD. ...The global prevalence of AD and the population affected by AD were estimated to be 2 …
BACKGROUND: Atopic dermatitis (AD) is the leading cause of the global burden from skin disease; no study has provided global a …
Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.
Sedeh FB, Henning MAS, Jemec GBE, Ibler KS. Sedeh FB, et al. Acta Derm Venereol. 2022 Aug 24;102:adv00764. doi: 10.2340/actadv.v102.2075. Acta Derm Venereol. 2022. PMID: 35818735 Free PMC article.
All randomized controlled trials investigating the efficacy of systemic treatments for moderate-to-severe atopic dermatitis in adults were included. Primary outcomes were the proportion of patients with atopic dermatitis achieving 50%, 75%, and 90% imp …
All randomized controlled trials investigating the efficacy of systemic treatments for moderate-to-severe atopic dermatitis in …
Nipple eczema: A systematic review and practical recommendations.
Reynaert V, Gutermuth J, Wollenberg A. Reynaert V, et al. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1149-1159. doi: 10.1111/jdv.18920. Epub 2023 Feb 16. J Eur Acad Dermatol Venereol. 2023. PMID: 36695082 Review.
The nipple is the focal point of the human breast and serves important physiological, sexual, and aesthetic purposes. It can be affected by atopic, irritant, and allergic contact eczema, which often reduce the patient's quality of life. ...
The nipple is the focal point of the human breast and serves important physiological, sexual, and aesthetic purposes. It can be affected by …
183 results